Reviewing the Hospitalization Criteria of Symptomatic Covid-19 Patients and Comparing them with National Therapeutic-diagnostic Guidelines of Covid-19

Document Type : Original Article

Authors

1 Instructor of Nursing, Department of Nursing, Asadabad School of Medical Sciences, Asadabad, Iran.

2 Instructor of Epidemiology, Department of Public Health, Asadabad School of Medical Sciences, Asadabad, Iran.

3 Professor of Physiology, Department of Anesthesiology, Hamadan University of Medical Sciences, Hamedan, Iran.

10.32592/JSMJ.23.1.9

Abstract

Background and Objectives At the outset of a new pandemic, when evidence related to predictors of disease is limited or ineffective, prioritization of hospitalization criteria can have a pivotal role in optimization of health-treatment services. This study was performed with the aim of reviewing the hospitalization criteria of symptomatic Covid-19 patients admitted to Ghaem Hospital of Asadabad city and comparing them with national therapeutic-diagnostic guidelines of Covid-19 in 2019-2021. Subjects and Methods This analytical cross-sectional study involved all symptomatic Covid-19 patients (n = 2286) hospitalized from the beginning of the pandemic until the end of the fifth surge of the disease (from March 2020 to August 2021). The tool used in this study was the checklist for gathering demographic and clinical information of Covid-19 patients. Statistical analysis was performed using the chi-square test. Results Our results showed that 47.9% of the patients had moderate symptoms and 49.1% of the patients had severe symptoms, and according to the guidelines, they had at least 3 symptoms. Conclusion The above-mentioned results indicate the good conformity of the hospitalization criteria of suspected Covid-19 patients admitted to the hospital with the national diagnostic-therapeutic guideline issued by the Ministry of Health and Medical Education (11th edition).

Keywords

Main Subjects


[1] Tavakoli A, Vahdat K, Keshavarz M. Novel coronavirus disease
2019 (COVID-19): an emerging infectious disease in the 21st
century. Iranian south medical journal. 2020 Jan 4;22(6):432-50.
[2] Kazeminia M, Jalali R, Vaisi-Raygani A, Khaledi-Paveh B, Salari
N, Mohammadi M, Sabbaghchi M. Fever and cough are two
important factors in identifying patients with the Covid-19: A
meta-analysis. J Mil Med. 2020 Feb 1;22(2):193-202.
[3] https://www.WHO.int/emergencies/diseases/novel-coron
avirus-2022
[4] https://Behdasht.gov.ir
[5] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H,
Lei CL, Hui DS, Du B. Clinical characteristics of coronavirus
disease 2019 in China. New England journal of medicine. 2020
Apr 30;382(18):1708-20. [10.1056/NEJMoa2002032] [PMID]
[6] Jaafarabadi M, Bagheri M, Shariat M, Raeisie K, Ranjbar A,
Ghafoori F, Haghollahi F. The evaluation of clinical symptoms
and underlying factors in infected patients with Covid-19.
[7] Golahdooz M, Taherizadeh M, Laali A, Khoonsari M, Ajdarkosh
H, Safarnezhad Tameshkel F, Faal M, Karbalaie Niya MH. A
review on coronavirus 2019 disease (COVID-19, SARS-CoV-2):
control and prevention. Razi Journal of Medical Sciences. 2020
Jul 10;27(5):98-107.
[8] Wu G, Yang P, Xie Y, Woodruff HC, Rao X, Guiot J, Frix AN, Louis
R, Moutschen M, Li J, Li J. Development of a clinical decision
support system for severity risk prediction and triage of COVID-
19 patients at hospital admission: an international multicentre
study. European Respiratory Journal. 2020 Aug 1;56(2).
[10.1183/13993003.01104-2020] [PMID]
[9] Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC.
Pathophysiology, transmission, diagnosis, and treatment of
coronavirus disease 2019 (COVID-19): a review. Jama. 2020
Aug 25;324(8):782-93. [10.1016/j.ijid.2020.06.082] [PMID]
[10] De Nardo P, Gentilotti E, Mazzaferri F, Cremonini E, Hansen P,
Goossens H, Tacconelli E, Mangoni ED, Florio LL, Zampino R,
Mele F. Multi-Criteria Decision Analysis to prioritize hospital
admission of patients affected by COVID-19 in low-resource
settings with hospital-bed shortage. International Journal of
Infectious Diseases. 2020 Sep 1;98:494-500. [10.1016/j.ijid.
2020.06.082] [PMID]
[11] Arman A, Tajik M, Nazemipour M, Ahmadinejad Z,
Shahrestanaki SK, Hazrati E, Mansournia N, Mansournia MA.
Risk factors of developing critical conditions in Iranian patients
with COVID-19. Global epidemiology. 2021 Nov 1;3:100046.
[10.1016/j.gloepi.2020.100046] [PMID]
[12] https://www.who.int/publications/who-guidelines
[13] Hadinejad Z, Saleh Tabari Y, Sajadi Z, Talebi Ghadicolaei H.
Clinical characteristics and risk factors of COVID-19 and related
deaths in elderly patients. Iranian Journal of Ageing. 2021 Mar
10;16(1):128-39. [10.32598/sija.16.1.658.2]
[14] Kim L, Garg S, O’Halloran A, Whitaker M, Pham H, Anderson EJ,
Armistead I, Bennett NM, Billing L, Como-Sabetti K, Hill M. Risk
factors for intensive care unit admission and in-hospital
mortality among hospitalized adults identified through the US
coronavirus disease 2019 (COVID-19)-associated
hospitalization surveillance network (COVID-NET). Clinical
infectious diseases. 2021 May 1;72(9):e206-14. [10.1093/
cid/ciaa1012 ] [PMID]
[15] Sheikhi F, Mirkazehi Rigi Z, Azarkish F, Kalkali S, Seid Abadi M,
Mirbaloochzehi A. Clinical and demographic characteristics of
patients with COVID-19 in Iranshahr Hospitals, southeastern Iran
in 2020. Journal of Marine Medicine. 2021 Mar 10;3(1):46-52.
[16] Liu L, Lei X, Xiao X, Yang J, Li J, Ji M, Du W, Tan H, Zhu J, Li B, Jin
Z. Epidemiological and clinical characteristics of patients with
coronavirus disease-2019 in Shiyan City, China. Frontiers in
cellular and infection microbiology. 2020 May 22;10:284 [10.
3389/fcimb.2020.00284 ] [PMID]
[17] Brandt JS, Hill J, Reddy A, Schuster M, Patrick HS, Rosen T,
Sauer MV, Boyle C, Ananth CV. Epidemiology of coronavirus
disease 2019 in pregnancy: risk factors and associations with
adverse maternal and neonatal outcomes. American journal of
obstetrics and gynecology. 2021 Apr 1;224(4):389-e1. [10.
1016/j.ajog.2020.09.043 ] [PMID]
[18] Lam C, Calvert J, Siefkas A, Barnes G, Pellegrini E, Green-Saxena
A, Hoffman J, Mao Q, Das R. Personalized stratification of
hospitalization risk amidst COVID-19: A machine learning
approach. Health policy and technology. 2021 Sep 1;10(3):
100554. [10.1016/j.hlpt.2021.100554 ] [PMID]
[19] Maleki H, Tabatabaie F, Bagherinik M, Azizmohamadi S, Laka S,
Mohajeri Iravani M. Some clinical features and supportive
therapies in Covid-19 patients died in Hajar Hospital, Tehran,
Iran. Complementary Medicine Journal. 2021 Sep 10;11(2):
154-65.